Publication of Prosus Shareholder Circular and Notice of Extraordinary General Meeting
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO ANY JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW.
PLEASE SEE THE IMPORTANT DISCLAIMERS AT THE END OF THIS ANNOUNCEMENT.
Prosus (Euronext Amsterdam: PRX; JSE: PRX)shareholders ("Prosus shareholders" or "Shareholders") are referred to the announcement made by the board of directors of Prosus ("Prosus Board") on Wednesday, 12 May 2021 ("Announcement") in relation to Prosus's intention to implement a proposed transaction involving, among other things, a voluntary exchange offer in terms of which, among other things, the holders of the N ordinary shares ("Naspers N Ordinary Shares") in the share capital of Naspers Limited ("Naspers") will be entitled, subject to the terms and conditions of the exchange offer, to exchange some of their Naspers N Ordinary Shares for newly issued ordinary shares N in the share capital of Prosus ("ProsusOrdinary Shares N") in accordance with the exchange ratio for the offer ("Proposed Transaction").
The Proposed Transaction is expected to result in a significant value unlock for Naspers and Prosus shareholders at the time of the transaction and in the future. The group is confronted with a complex structural issue related to the size of Naspers on the SWIX and the group believes the Proposed Transaction clearly presents the steps to a practical and simple end state, while preserving all future optionality to take further steps to reduce the discount to the group‘s net asset value ("NAV"). In addition, the Proposed Transaction is expected to:
- meaningfully and sustainably reduce Naspers's overweight position on the SWIX, thereby directly addressing what is believed to be a key driver of the discount to Naspers NAV;
- increase the Prosus free float materially, with an expected commensurate increase in overall trading liquidity, market index weightings and positive trading dynamics;
- maintain the current voting position, the legal entity structure and group tax situation of Naspers and Prosus; and
- maintain our operational, strategic and financial flexibility to create value over the long term and take further value creating actions.
Prosus shareholders were advised in the Announcement that their approval of certain matters relating to the Proposed Transaction is required and that further details would be provided for this purpose in due course, including documents relating to the convocation of a Prosus extraordinary general meeting.
The Prosus Board is pleased to announce that the notice that convenes the extraordinary general meeting of Prosus shareholders ("EGM Notice") to be held virtually at 14:00 (CET/SAST) on Friday, 9 July 2021 ("EGM") has been made available by Prosus today. At the EGM, the Shareholders will consider and, if deemed fit, adopt the resolution required to be adopted by the Shareholders to implement the Proposed Transaction.
In addition, a circular to the Shareholders has been made available by Prosus today ("Circular"). The Circular, among other things:
- explains the Proposed Transaction, its expected benefits for Prosus and all stakeholders, including Shareholders, and its expected benefits for the Naspers N Shareholders;
- provides Shareholders with further information regarding the Proposed Transaction; and
- incorporates the EGM Notice.
The EGM Notice, the Circular as well as other relevant EGM documents ("EGM Materials") are available upon request and free of charge at the office of Prosus, Gustav Mahlerplein 5, 1082 MS Amsterdam, email: firstname.lastname@example.org or via www.prosus.com/investors/egm. The EGM Materials documents can also be digitally provided via ABN AMRO Bank, email: email@example.com.
In South Africa, additional print copies of the EGM Materials, including the Circular, can be obtained from the offices of Prosus's JSE Sponsor, Investec Bank Limited, at their address provided in the "Corporate Information" section of the Circular during normal business hours from today, 27 May 2021, up to and including the date of the EGM, being Friday, 9 July 2021.
The Capitalised terms not defined herein shall have the meanings ascribed thereto in the Circular.
2. RESOLUTION AND EXTRAORDINARY GENERAL MEETING
The EGM will be held virtually at 14:00 (CET/SAST) on Friday, 9 July 2021. Formally, the EGM will be held at ABN AMRO, Gustav Mahlerlaan 10, 1082 PP Amsterdam, the Netherlands, where Shareholders will consider and, if deemed fit, adopt the resolution (as set out in the EGM Notice).
In summary, at the EGM, a resolution will be proposed to the General Meeting, comprising of the following components:
- approve the Exchange Offer pursuant to section 2:107a of the Dutch Civil Code and section 24.1 of the Articles of Association;
- approve the Prosus Articles Amendment;
- designate the Board as the corporate body authorised to issue shares and exclude or limit pre-emptive rights; and
- authorise the Board to resolve that the company acquires shares in its own capital.
Please refer to the EGM Notice for a detailed description of the proposal to be voted on by Shareholders at the EGM, as well as the procedure to be followed by Shareholders in order to exercise their votes at the EGM. Shareholders should consider the Circular and EGM Notice in full.
3. SALIENT DATES OF THE EGM AND THE PROPOSED TRANSACTION
The following indicative timetable sets out the expected dates for the EGM and the Proposed Transaction:
Last day to trade in Prosus Ordinary Shares N on the JSE
Tuesday, 8 June
Last day to trade in Prosus Ordinary Shares N on
Wednesday, 9 June
Record date to be eligible to vote and participate in the
Friday, 11 June
EGM held virtually at ABN AMRO, Gustav
Friday, 9 July
Results of the General Meeting expected to be released
Friday, 9 July
Prospectus is issued and the Exchange Offer opens
Monday, 12 July
Last day to trade in Naspers N Ordinary Shares to be
Tuesday, 10 August
Naspers N Ordinary Shares trade "ex" the entitlement to
Wednesday, 11 August
Cash value for fractional entitlements announced on JSE
Thursday, 12 August
Exchange Offer closes on
Friday, 13 August
Record date for the Exchange Offer at 17:00 on
Friday, 13 August
Issue of New Prosus Ordinary Shares N and Settlement
Monday, 16 August
4. CROSS-HOLDING AGREEMENT
Shareholders are advised that on 27 May 2021, Prosus and Naspers entered into the Cross-Holding Agreement, which regulates certain matters arising in relation to the Cross-Holding Arrangement as part of the implementation of the Proposed Transaction. The Cross-Holding Agreement is intended to ensure the efficient and effective ongoing interaction between Prosus and Naspers by eliminating the need for round-tripping of cash or assets in the Cross-Holding Structure thereby removing financial and administrative inefficiencies. The Cross-Holding Agreement and the Prosus Articles Amendment together give effect to the Cross-Holding Arrangement.
The rights and obligations of the parties under the Cross-Holding Agreement are subject to certain conditions precedent, including the Exchange Offer becoming unconditional in accordance with its terms.
JSE sponsor to Prosus
Investec Bank Limited
Dutch Legal Adviser to Prosus
Allen & Overy LLP
South African Legal Adviser to Prosus
US Legal Adviser to Prosus
Cravath, Swaine & Moore LLP
Joint Financial Advisers to Prosus
Goldman Sachs Bank Europe SE
Morgan Stanley & Co. International plc
Prosus is a global consumer internet group and one of the largest technology investors in the world. Operating and investing globally in markets with long-term growth potential, Prosus builds leading consumer internet companies that empower people and enrich communities.
The group is focused on building meaningful businesses in the online classifieds, food delivery, payments and fintech, and education technology sectors in markets including India, Russia and Brazil. Through its ventures team, Prosus invests in areas including health, logistics, blockchain, and social commerce. Prosus actively seeks new opportunities to partner with exceptional entrepreneurs who are using technology to improve people's everyday lives.
Every day, millions of people use the products and services of companies that Prosus has invested in, acquired or built, including Avito, Brainly, BYJU'S, Bykea, Codecademy, DappRadar, DeHaat, dott, ElasticRun, eMAG, Eruditus, Honor, iFood, Klar, LazyPay, letgo, Meesho, Movile, OLX, PayU, Quick Ride, Red Dot Payment, Remitly, Republic, SimilarWeb, Shipper, Skillsoft, SoloLearn, Swiggy, and Udemy.
Hundreds of millions of people have made the platforms of Prosus’s associates a part of their daily lives. For listed companies where we have an interest, please see: Tencent (www.tencent.com), Mail.ru (www.corp.mail.ru), Trip.com Group Limited (www.trip.com), and DeliveryHero (www.deliveryhero.com).
Today, Prosus companies and associates help improve the lives of around a fifth of the world's population.
Prosus has a primary listing on Euronext Amsterdam (AEX:PRX) and secondary listings on the Johannesburg Stock Exchange (XJSE:PRX) and a2X Markets (PRX.AJ). Prosus is majority owned by Naspers. For more information, please visit www.prosus.com.
This press release contains information within the meaning of Article 7(1) of the European Market Abuse Regulation (596/2014).
Shareholders should note that the Prosus Board reserves the right, in its discretion, to decide not to proceed with the Proposed Transaction and, as such, the Proposed Transaction may or may not proceed.
This announcement is for information purposes only and is not an offer to sell or the solicitation of an offer to buy securities and neither this document nor anything herein nor any copy thereof may be taken into or distributed, directly or indirectly, in or into any jurisdiction in which to do so would be prohibited by applicable law.
There will be no public offer of any securities in the United States. The securities referred to in this announcement have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”), and will not be offered or sold, directly or indirectly, in or into the United States or to, or for the account or benefit of, any “U.S. person” as defined in Regulation S under the Securities Act except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act.
The information contained in this announcement does not constitute or form a part of any offer to the public for the sale of, or subscription for, or an invitation, advertisement or the solicitation of an offer to purchase and/or subscribe for, securities as defined in and/or contemplated by the South African Companies Act, No. 71 of 2008 ("South African Companies Act"). Accordingly, this announcement does not, nor does it intend to, constitute a “registered prospectus” or an advertisement relating to an offer to the public, as contemplated by the South African Companies Act and no prospectus has been, or will be, filed with the South African Companies and Intellectual Property Commission in respect of this announcement.
The information contained in this announcement constitutes factual information as contemplated in Section 1(3)(a) of the South African Financial Advisory and Intermediary Services Act, 37 of 2002, as amended ("FAIS Act") and should not be construed as an express or implied recommendation, guide or proposal that any particular transaction in respect of the Prosus Ordinary Shares N and/or Naspers N Ordinary Shares or in relation to the business or future investments of Prosus and/or Naspers, is appropriate to the particular investment objectives, financial situations or needs of a prospective investor, and nothing contained in this announcement should be construed as constituting the canvassing for, or marketing or advertising of, financial services in South Africa. Prosus is not a financial services provider licensed as such under the FAIS Act.
In member states of the European Economic Area (“EEA”) (each, a “Relevant Member State”) no action has been undertaken or will be undertaken to make an offer to the public of Securities requiring publication of a prospectus in any Relevant Member State. As a result, this announcement and any offer if made subsequently is directed exclusively at persons who are “qualified investors” within the meaning of the Prospectus Regulation (“Qualified Investors”). For these purposes, the expression “Prospectus Regulation” means Regulation 2017/1129/EU (and amendments thereto) and includes any relevant implementing measure in the Relevant Member State.
This announcement does not constitute a prospectus within the meaning of the Prospectus Regulation and has not been approved by the Dutch Authority for the Financial Markets (Stichting Autoriteit Financiële Markten).
In the United Kingdom this announcement is only being distributed to, and is only directed at, and any investment or investment activity to which this announcement relates is available only to, and will be engaged in only with, qualified investors (as defined under Article 2(e) of Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018) who are (i) investment professionals falling with Article 19(5) of the UK Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”); (ii) high net worth entities falling within Article 49(2)(a) to (d) of the Order, or (iii) other persons to whom it may otherwise be lawfully communicated (all such persons together being referred to as “relevant persons”). Persons who are not relevant persons should not take any action on the basis of this announcement and should not act or rely on it.
The release, publication or distribution of this announcement in jurisdictions other than South Africa may be restricted by law and therefore persons into whose possession this announcement comes should inform themselves about, and observe, any applicable restrictions or requirements. Any failure to comply with such restrictions may constitute a violation of the securities laws of any such jurisdiction. To the fullest extent permitted by applicable law, Prosus disclaims any responsibility or liability for the violation of such requirements by any person.
It is the responsibility of person (including, without limitation, nominees, agents and trustees for such persons) wishing to receive this announcement and/or participate in the Proposed Transaction, or a component thereof, to satisfy themselves as to the full observance of the applicable laws of any relevant territory, including obtaining any requisite governmental or other consents, observing any other requirements or formalities and paying any issue, transfer or other taxes due in such territories. Further information pertaining to the Proposed Transaction will be provided in due course pursuant to the documentation to be released by Prosus in relation to the Proposed Transaction (the "Transaction Documentation").
Investors are advised to read the Transaction Documentation, which will contain the terms and conditions of the Proposed Transaction, with care and in full. Any decision to approve the resolution required to implement the Proposed Transaction or analysis of and/or election in respect of the Proposed Transaction and/or other matters dealt with in the Transaction Documentation should be made only on the basis of such information.
Application will be made for all of the Prosus Ordinary Shares N proposed to be issued pursuant to the Proposed Transaction to be admitted to listing and trading on the AEX and on the Main Board of the JSE and A2X Markets. The Transaction Documentation to be issued by Prosus in respect of, among other things, the Proposed Transaction will be made available in due course, subject to applicable securities laws, on www.prosus.com. Investors should have regard to the Transaction Documentation before deciding to elect to participate in the Proposed Transaction.
Any financial adviser of Prosus is acting exclusively for Prosus and no one else in connection with the Proposed Transaction. No financial adviser will regard any other person as its client in relation to the Proposed Transaction and will not be responsible to anyone other than Prosus for providing the protections afforded to its client nor for giving advice in relation to the Proposed Transaction or any other transaction or arrangement referred to in this announcement.
No representation or warranty, express or implied, is made or given, and no responsibility is accepted, by or on behalf of any financial adviser or any of its affiliates or any of its respective directors, officers or employees or any other person, as to the accuracy, completeness, fairness or verification of the information or opinions contained this announcement and nothing contained in this announcement is, or shall be relied upon as, a promise or representation by any financial adviser or any of their respective affiliates as to the past or future. Accordingly, any financial advisers and its affiliates and respective directors, officers and employees disclaim, to the fullest extent permitted by applicable law, all and any liability, whether arising in tort or contract or that they might otherwise be found to have in respect of this announcement and/or any such statement.
Nothing contained in this announcement constitutes, or is intended to constitute, investment, tax, legal, accounting or other professional advice.
This announcement contains statements about Prosus and/or Naspers that are, or may be, forward-looking statements. All statements (other than statements of historical fact) are, or may be deemed to be, forward-looking statements, including, without limitation, those concerning: strategy; the economic outlook for the industries in which Prosus and/or Naspers operates or invests as well as markets generally; production; cash costs and other operating results; growth prospects and outlook for operations and/or investments, individually or in the aggregate; liquidity, capital resources and expenditure, statements in relation to the approval by shareholders or implementation of the Proposed Transaction and/or the benefits of the Proposed Transaction. These forward-looking statements are not based on historical facts, but rather reflect current expectations concerning future results and events and generally may be identified by the use of forward-looking words or phrases such as "believe", "aim", "expect", "anticipate", "intend", "foresee", "forecast", "likely", "should", "planned", "may", "estimated", "potential" or similar words and phrases. Examples of forward-looking statements include statements regarding a future financial position or future profits, cash flows, corporate strategy, implementation of the Proposed Transaction and/or the benefits of the Proposed Transaction, anticipated levels of growth, estimates of capital expenditures, acquisition and investment strategy, expansion prospects or future capital expenditure levels and other economic factors, such as, among others, growth and interest rates.
By their nature, forward-looking statements involve known and unknown risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. Prosus cautions that forward-looking statements are not guarantees of future performance. Actual results, financial and operating conditions, returns and the developments within the industries and markets in which Prosus and/or Naspers operates and/or invests may differ materially from those made in, or suggested by, the forward-looking statements contained in this announcement. All these forward-looking statements are based on estimates, predictions and assumptions, as regards Prosus or Naspers, all of which estimates, predictions and assumptions, although Prosus believes them to be reasonable, are inherently uncertain and may not eventuate or eventuate in the manner Prosus expects. Factors which may cause the actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied in those statements or assumptions include matters not yet known to Prosus or not currently considered material by Prosus.
Investors should keep in mind that any forward-looking statement made in this announcement or elsewhere is applicable only at the date on which such forward-looking statement is made. New factors that could cause the business of Prosus or Naspers not to develop as expected may emerge from time to time and it is not possible to predict all of them. Further, the extent to which any factor or combination of factors may cause actual results, performance or achievement to differ materially from those contained in any forward-looking statement is not known. Prosus has no duty to, and does not intend to, update or revise the forward-looking statements contained in this announcement or any other information herein, except as may be required by law. Any forward-looking statement has not been reviewed nor reported on by Prosus's external auditor or any other expert.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
For more information:
Sarah Ryan, International Media Relations
Tel: + 31 6 29721038
Eoin Ryan, Head of Investor Relations
Tel: +1 347-210-4305
Shamiela Letsoalo, South Africa Media Relations
Tel: + 27 78 802 6310
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Verimatrix To Highlight Success In Enabling Secure Virtual Hollywood Events at Variety Entertainment & Technology Summit16.9.2021 17:45:00 CEST | Press release
Regulatory News: Verimatrix, (Paris:VMX), the leader in powering the modern connected world with people-centered security, today announced that Jon Samsel, Senior Vice President of Marketing, will discuss the value of harnessing security as a differentiator for the M&E industry during the upcoming virtual Variety Entertainment & Technology Summit. On Thursday, September 23, 2021 from 10:50 to 11:20 a.m. Pacific Time, Samsel will take part in a panel alongside Little Cinema Digital CEO Jay Rinsky and moderator Todd Spangler, NY Digital Editor at Variety. Register for free today. Titled, “Security That's Transforming Hollywood: The Little Cinema Digital Story,” the online event serves as an opportunity for attendees to learn how Verimatrix and Little Cinema Digital collaborated to transform the traditional Hollywood movie premiere business into an immersive virtual event platform that breaks down traditional limitations of venue capacities or locations. By leading with security, the comp
Exactech’s Equinoxe® Stemless Shoulder Replacement System Debuts in Europe16.9.2021 16:06:00 CEST | Press release
Exactech, a developer and producer of innovative implants, instrumentation and smart technologies for joint replacement surgery, announced today that the first anatomic total shoulder surgery has been performed in Europe using its bone-conserving, 3D-printed Equinoxe® Stemless Shoulder. Prof. Mark Tauber, MD, PhD, of Athos Klinik in Munich, Germany, performed the first surgery earlier this month. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210916005561/en/ Prof. Mark Tauber, MD, PhD, of Athos Klinik in Munich, Germany performed the first surgery in Europe using Exactech's bone-conserving, 3D-printed Equinoxe® Stemless Shoulder (Photo: Business Wire) “It was wonderful to be the first user of the Exactech Stemless humeral component in Europe,” Tauber said. “I’ve used stemless implants with various systems since 2007, so I know what we are talking about and have to congratulate Exactech for this product. The user-friendly in
Boehringer Ingelheim Enters Clinical Collaboration with Amgen to Study BI 1701963, a SOS1::pan-KRAS Inhibitor, in Combination with LUMAKRAS™ (sotorasib), a KRAS G12C Inhibitor16.9.2021 14:00:00 CEST | Press release
Boehringer Ingelheim today announced a clinical phase I collaboration with Amgen to evaluate the combination of BI 1701963, the first and most advanced SOS1::pan-KRAS inhibitor exhibiting activity against a broad spectrum of KRAS alleles, and LUMAKRAS™ (sotorasib), the first US Food and Drug Administration (FDA) approved KRASG12C inhibitor for adult patients with locally advanced or metastatic non-small cell lung cancer. The trial will investigate potential synergistic effects of this combination, possibly improving therapeutic outcomes beyond those of KRASG12C inhibitor therapy alone, specifically for people living with lung and colorectal cancers. Preclinical data suggest that the combination of a KRASG12C inhibitor with a SOS1::pan-KRAS inhibitor may result in increased anti-tumor activity in KRAS G12C-driven cancers based on the complementary mechanisms of these targeted oncology agents.1 2 By shifting the equilibrium from active KRAS towards the inactive form, SOS1::pan-KRAS inhib
SoftServe Wins Gold in 2021 Brandon Hall Group Excellence in Leadership Development Awards16.9.2021 13:05:00 CEST | Press release
SoftServe, a leading digital authority and consulting company has won Gold in the Best Advance in Coaching and Mentoring nomination at the 2021 Brandon Hall Group Excellence in Leadership Development Awards. The company was recognized for a unique learning ecosystem that implements mentoring and coaching practices to help associates grow, gain new competencies, and hone their leadership skills. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210916005049/en/ SOFTSERVE WINS GOLD IN 2021 BRANDON HALL GROUP EXCELLENCE IN LEADERSHIP DEVELOPMENT AWARDS (Graphic: Business Wire) Individual-oriented learning at SoftServe is part of the corporate learning and development ecosystem. SoftServe University offers learning solutions in over 20 different formats. Besides trainings, long-term, conventional, and e-learning programs, mentoring and coaching enable associates to gain knowledge and experience faster, improving employee performanc
Entersekt Enables FIDO Authentication for Improved Security, User Experience, and Customer Choice16.9.2021 13:00:00 CEST | Press release
CYBER attacks pose a massive risk for financial institutions. The cost of data breaches averages tens of millions of dollars, and other after-effects are often far-reaching for organizations and their customers. At the root of these breaches are passwords – in an estimated 80% of cases. “Eliminating passwords and replacing them with more secure and user-friendly solutions is critical,” says Entersekt’s SVP Product, Christian Ali. Ali says there’s been a massive surge in online fraud in the past 18 months. Existing methods of authenticating consumers’ identities and transactions typically rely on outdated, less secure solutions like passwords or OTPs, while more secure solutions often require a mobile app. In addition, poor user experience often leads to cart abandonment – and lost sales. Users are frustrated and banks are at risk. To address the divide between strong security on the one hand and good user experience on the other, Entersekt has expanded its authentication suite to inclu
Philip Morris International Announces Unconditional Offer for Vectura Group PLC16.9.2021 11:48:00 CEST | Press release
PMI Global Services Inc. (PMI) (NYSE: PM) today announced that its offer for Vectura Group plc (Vectura) (LSE: VEC) has become unconditional, having received valid acceptances for or acquired 74.77 % of Vectura shares, in excess of the 50% required under the acceptance condition, as well as confirming that all other conditions to the offer have been satisfied or waived. PMI has extended the offer to allow for the tender of further shares. “We have reached an important milestone in our acquisition of Vectura and are pleased to have secured over 74% of the company’s shares, in excess of the 50% required to make our offer unconditional and PMI the majority shareholder," said PMI’s Chief Executive Officer, Jacek Olczak. "We are very excited about the critical role Vectura will play in our Beyond Nicotine strategy and look forward to working with Vectura’s scientists and providing them with the resources and expertise to grow their business to help us achieve our goal of generating at least
Argenta Acquires Top Clinical Research Organization Klifovet to Enhance Services and Expand Global Footprint16.9.2021 11:10:00 CEST | Press release
Argenta, the only combined global contract research organization (CRO) and contract development & manufacturing organization (CDMO) dedicated to animal health, announced today that it has acquired Klifovet, the leading CRO and Regulatory Affairs consultancy organization in Europe. Financial details of the transaction were not disclosed. Klifovet founder and CEO Dr. Klaus Hellmann will continue to lead Klifovet and will join Argenta’s senior leadership team. Founded in 1997 by Dr. Klaus Hellmann and located in Munich, Germany, Klifovet has built a leading reputation in the animal health industry, providing extensive expertise in clinical research and regulatory affairs. Its ~50 employees have had successful involvement in hundreds of studies, and their expertise and knowledge has been critical to numerous marketing authorizations for pharmaceutical, biological, immunological, and novel therapies. Its client base comprises the world’s top animal health and nutrition companies as well as
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom